Tardive Dysphoria With Selective-Serotonin Reuptake Inhibitors Treated Successfully With Atypical Antidepressants: A Case Series From Tertiary Hospital Setting

被引:0
|
作者
Bhattacharjee, Debanjan [1 ]
Mahto, Sumit Kumar [2 ]
Prithviraj, H. K. Tejaswi [3 ]
Poornima, H. K. Surakshitha [4 ]
机构
[1] Cent Hosp Dhori, Psychiat, Phusro, India
[2] All India Inst Med Sci, Pharmacol, Deogarh, India
[3] Adichunchanagiri Inst Med Sci, Psychiat, Mandya, India
[4] Hosp & Res Inst, Sri Chamundeshwari Med Coll, Psychiat, Channapatna, India
关键词
treatment-resistant depression; selective serotonin reuptake inhibitors; antidepressant; mood disorders; tardive dysphoria;
D O I
10.7759/cureus.56684
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tardive dysphoria (TDp) is a phenomenon characterized by the delayed onset or worsening of depressive symptoms following the discontinuation or alteration of antidepressant medications. TDp is a recently defined, under-recognized, and understudied condition. We present a series of five TDp cases exploring the diverse presentations, management strategies, and associated medical conditions. In all the cases, TDp manifested after prolonged use of selective serotonin reuptake inhibitors (SSRIs). All cases were successfully managed with atypical antidepressants. These cases offer insight into TDp, providing clinicians and researchers with examples of atypical trajectories in depressive symptomatology.
引用
收藏
页数:6
相关论文
共 34 条
  • [21] Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study
    Lupattelli, Angela
    Wood, Mollie
    Lapane, Kate
    Spigset, Olav
    Nordeng, Hedvig
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (10) : 1266 - 1276
  • [22] May depressed and anxious patients with carcinoid syndrome benefit from treatment with selective serotonin reuptake inhibitors (SSRIs)?: findings from a case report
    Nobels, Anne
    Geboes, Karen
    Lemmens, Gilbert M. D.
    [J]. ACTA ONCOLOGICA, 2016, 55 (11) : 1370 - 1372
  • [23] Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports
    Kogut, Christopher
    Crouse, Ericka Breden
    Vieweg, W. Victor R.
    Hasnain, Mehrul
    Baranchuk, Adrian
    Digby, Genevieve C.
    Koneru, Jayanthi N.
    Fernandez, Antony
    Deshmukh, Anand
    Hancox, Jules C.
    Pandurangi, Ananda K.
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2013, 4 (05) : 189 - 198
  • [25] Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors
    Berg, Alfred O.
    Piper, Margaret
    Armstrong, Katrina
    Botkin, Jeffrey
    Calonge, Ned
    Haddow, James
    Hayes, Maxine
    Kaye, Celia
    Phillips, Kathryn A.
    Richards, Carolyn Sue
    Scott, Joan A.
    Strickland, Ora L.
    Teutsch, Steven
    [J]. GENETICS IN MEDICINE, 2007, 9 (12) : 819 - 825
  • [26] Novel Role Of Tofisopam In Organic Catatonia : Hypothesis Generated From A Case Series In A Tertiary Medical College And Hospital Setting
    Dash, Siddhartha Sankar
    Dr Anshuman
    Kumar, Sumit
    Pani, Sanjay Kumar
    Ravan, Jayaprakash Russell
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S213 - S214
  • [27] A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series
    Matsunaga, Hisato
    Matsui, Tokuzo
    Ohya, Kenzo
    Okino, Kenya
    Hayashida, Kazuhisa
    Maebayashi, Kensei
    Kiriike, Nobuo
    Stein, Dan J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2006, 10 (02) : 142 - 145
  • [28] Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: A six-month follow-up case series
    Dell'Osso, Bernardo
    Mundo, Emanuela
    Altamura, A. Carlo
    [J]. CNS SPECTRUMS, 2006, 11 (11) : 879 - 883
  • [29] Variants of the Serotonin Transporter Gene, Selective Serotonin Reuptake Inhibitors, and Bone Mineral Density in Risperidone-Treated Boys: A Reanalysis of Data From a Cross-Sectional Study With Emphasis on Pharmacogenetics
    Calarge, Chadi A.
    Ellingrod, Vicki L.
    Zimmerman, Bridget
    Bliziotes, Michael M.
    Schlechte, Janet A.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (12) : 1685 - 1690
  • [30] Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series
    Michele Fornaro
    [J]. Annals of General Psychiatry, 10